DK694487D0 - 1-acyl-2,3-dihydro-4(1h)-quinolinon-4-oximderivater og fremgangsmaade til fremstilling af samme - Google Patents

1-acyl-2,3-dihydro-4(1h)-quinolinon-4-oximderivater og fremgangsmaade til fremstilling af samme

Info

Publication number
DK694487D0
DK694487D0 DK694487A DK694487A DK694487D0 DK 694487 D0 DK694487 D0 DK 694487D0 DK 694487 A DK694487 A DK 694487A DK 694487 A DK694487 A DK 694487A DK 694487 D0 DK694487 D0 DK 694487D0
Authority
DK
Denmark
Prior art keywords
oxyme
quinolinon
dihydro
acyl
derivatives
Prior art date
Application number
DK694487A
Other languages
English (en)
Other versions
DK694487A (da
DK171379B1 (da
Inventor
Ei Mochida
Akio Uemura
Kazuo Kato
Hiroki Tokunaga
Akinori Haga
Original Assignee
Mochida Pharm Co Ltd
Hodogaya Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP62092788A external-priority patent/JPS63239270A/ja
Application filed by Mochida Pharm Co Ltd, Hodogaya Chemical Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of DK694487D0 publication Critical patent/DK694487D0/da
Publication of DK694487A publication Critical patent/DK694487A/da
Application granted granted Critical
Publication of DK171379B1 publication Critical patent/DK171379B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK694487A 1986-05-02 1987-12-30 1-Acyl-2,3-dihydro-4(1H)-quinolinon-4-oxim-0-sulfonsyrederivater, fremgangsmåder til fremstilling af samme, farmaceutisk sammensætning omfattende samme samt mellemproduktforbindelse til anvendelse ved fremgangsmåden DK171379B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP10284786 1986-05-02
JP10284786 1986-05-02
JP9278887 1987-04-15
JP62092788A JPS63239270A (ja) 1986-05-02 1987-04-15 1−アシル−2,3−ジヒドロ−4(1h)−キノリノン−4−オキシム誘導体、その製法、およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去剤
JP8700276 1987-05-01
PCT/JP1987/000276 WO1987006580A1 (en) 1986-05-02 1987-05-01 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivatives

Publications (3)

Publication Number Publication Date
DK694487D0 true DK694487D0 (da) 1987-12-30
DK694487A DK694487A (da) 1988-03-02
DK171379B1 DK171379B1 (da) 1996-10-07

Family

ID=26434165

Family Applications (1)

Application Number Title Priority Date Filing Date
DK694487A DK171379B1 (da) 1986-05-02 1987-12-30 1-Acyl-2,3-dihydro-4(1H)-quinolinon-4-oxim-0-sulfonsyrederivater, fremgangsmåder til fremstilling af samme, farmaceutisk sammensætning omfattende samme samt mellemproduktforbindelse til anvendelse ved fremgangsmåden

Country Status (18)

Country Link
US (2) US4839368A (da)
EP (1) EP0243982B1 (da)
AU (2) AU596657B2 (da)
CA (1) CA1314888C (da)
DE (1) DE3769358D1 (da)
DK (1) DK171379B1 (da)
ES (1) ES2036542T3 (da)
FI (1) FI90071C (da)
GR (1) GR3001800T3 (da)
HU (1) HU199803B (da)
IE (1) IE60105B1 (da)
IL (1) IL82399A0 (da)
NO (1) NO174465C (da)
NZ (1) NZ220168A (da)
RU (1) RU1779246C (da)
SU (1) SU1722227A3 (da)
WO (1) WO1987006580A1 (da)
ZW (1) ZW7887A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839368A (en) * 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
JP2602037B2 (ja) * 1987-10-31 1997-04-23 持田製薬株式会社 1−アシル−2,3−ジヒドロ−4(1h)−キノリノン−4−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物
TW234124B (da) * 1992-07-15 1994-11-11 Sumitomo Chemical Co
DK0765314T3 (da) 1994-06-15 2003-08-25 Otsuka Pharma Co Ltd Benzoheterocykliske derivater, der kan anvendes som vasopressin- eller oxytocinmodulatorer
HN2000000203A (es) 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
GB2532990A (en) 2014-12-05 2016-06-08 Schlumberger Holdings Corrosion inhibition
GB2543498A (en) 2015-10-19 2017-04-26 Schlumberger Holdings Corrosion inhibition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013662A (en) * 1974-12-19 1977-03-22 Pfizer Inc. Alkyl and benzyl 6,7-dialkoxy-2-methyl-4-oxo-1,2,3,4-tetrahydroquinoline-1-carboxylates
US3976650A (en) * 1975-11-04 1976-08-24 Pfizer Inc. Process for preparing optically active 6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid ester analgesics
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
GB2092130B (en) * 1980-07-28 1984-05-10 Hodogaya Chemical Co Ltd 4-oximino-1,2,3,4-tetrahydroquinoline derivatives
GB2081091B (en) * 1980-07-28 1984-03-07 Mochida Pharm Co Ltd Hypotensive diuretic pharmaceutical compositions containing tetrahydroquinoline derivatives
US4421919A (en) * 1980-07-28 1983-12-20 Hodogaya Chemical Co., Ltd. 4-Oximino-1,2,3,4-tetrahydroquinoline derivatives
US4521607A (en) * 1981-02-27 1985-06-04 Takeda Chemical Industries, Ltd. Chromanyl glycines
CA1189078A (en) * 1982-07-30 1985-06-18 Hodogaya Chemical Co., Ltd. Process for producing 4-oximino-1,2,3,4- tetrahydroquinoline derivatives and said derivatives produced thereby
DE3416695A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
PH21213A (en) * 1984-10-26 1987-08-21 Fujisawa Pharmaceutical Co Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same
DE3660255D1 (en) * 1985-04-12 1988-07-07 Ciba Geigy Ag Oxime sulphonates containing reactive groups
US4839368A (en) * 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives

Also Published As

Publication number Publication date
NO875495L (no) 1988-03-01
FI875771A0 (fi) 1987-12-30
US5077410A (en) 1991-12-31
FI90071B (fi) 1993-09-15
NZ220168A (en) 1990-02-26
HUT47912A (en) 1989-04-28
NO174465C (no) 1994-05-11
ZW7887A1 (en) 1987-09-09
AU596657B2 (en) 1990-05-10
NO174465B (no) 1994-01-31
SU1722227A3 (ru) 1992-03-23
EP0243982B1 (en) 1991-04-17
GR3001800T3 (en) 1992-11-23
US4839368A (en) 1989-06-13
CA1314888C (en) 1993-03-23
HU199803B (en) 1990-03-28
DE3769358D1 (de) 1991-05-23
IL82399A0 (en) 1987-11-30
NO875495D0 (no) 1987-12-30
EP0243982A1 (en) 1987-11-04
IE60105B1 (en) 1994-06-01
DK694487A (da) 1988-03-02
FI90071C (fi) 1993-12-27
IE871154L (en) 1987-11-02
RU1779246C (ru) 1992-11-30
ES2036542T3 (es) 1993-06-01
FI875771A7 (fi) 1987-12-30
AU630716B2 (en) 1992-11-05
WO1987006580A1 (en) 1987-11-05
AU7244187A (en) 1987-11-05
AU5861890A (en) 1990-11-15
DK171379B1 (da) 1996-10-07

Similar Documents

Publication Publication Date Title
DK146489D0 (da) Fremgangsmaade til fremstilling af 2',3'-dideoxy-2',3'-didehydronucleosider
DK61792D0 (da) Fremgangsmaade til fremstilling af 2-chlor-4,6-diamino-5-cyano-pyrimidin
DK328687D0 (da) Fremgangsmaade til halogenering af ergotalkaloider i 2-stilling, saaledes halogenerede derivater og disses anvendelse
DK581688D0 (da) L-tyrosinderivater og fremgangsmaade til fremstilling af samme
DK379985A (da) Fremgangsmaade til fremstilling af 6-chlor-n-methyl-2,3,4,5-tetrahydro-lh-benzazepin
DK401787D0 (da) Spraenghoved og metode til fremstilling af samme
DK154963C (da) Fremgangsmaade til fremstilling af pulverformet, fritflydende tocoferylsuccinat
DK153085D0 (da) Pullulanaselignende enzymer, fremgangsmaade til fremstilling deraf og fremgangsmaade til forsukring af stivelse dermed
DK694487D0 (da) 1-acyl-2,3-dihydro-4(1h)-quinolinon-4-oximderivater og fremgangsmaade til fremstilling af samme
DK164853C (da) Fremgangsmaade til fremstilling af substituerede og usubstituerede 2-oe(1-carbamoyl-1,2-dimethylpropyl)-carbamoylaa-3-quinolincarboxyl-,-nicotin- og -benzoesyrer
DK189088D0 (da) Fremgangsmaade til fremstilling af alfa-(1-metylaetyl)-3,4-dimetoxybenzenacetonitril
DK329787A (da) Fremgangsmaade til fremstilling af mercaptoacylprolinderivater
DK231987A (da) Fremgangsmaade til fremstilling af 2,3-epoxyamider
DK489087D0 (da) Fremgangsmaade til fremstilling af alfa-n-(hypoxanthin-9-yl)-pentyloxycarbonyl)-arginin
DK417787A (da) Fremgangsmaade til fremstilling af 7-oxo-4-thia-1-azabicyclo-(3,2,0)hept-2-en-derivater
DK413787A (da) Fremgangsmaade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK84987D0 (da) Kontinuerlig fremgangsmaade til fremstilling af o,o-di-la-vere-alkylchlorthiophosphat
DK358386A (da) Fremgangsmaade til fremstilling af alkyl-2-carboalkoxy-3,4-dialkoxybenzencarbamater
KR880701229A (ko) 1-아실-2,3-디히드로-4(1h)-퀴놀리논-4-옥심유도체
DK587287A (da) Fremgangsmaade til fremstilling af 2-guanidinotiazolderivater
DK555087A (da) Fremgangsmaade til fremstilling af n-acyl-n-alkyl-2,6-dialkyl-3-chloraniliner
DK435085A (da) Fremgangsmaade til fremstilling af 5,6-dialkoxy-4-alkyl-2(1h)-quinazolinoner
DK216585D0 (da) Beta-carbolin-3-oxadiazolylderivater og fremgangsmaade til fremstilling af samme
DK636887D0 (da) Fremgangsmaade til fremstilling af 17aalfa-hydroxy-d-homo-1,4-pregnadien-3,20-dion
DK135589D0 (da) Fremgangsmaade til fremstilling af 1-substituerede 5-amino-1h-imidazol-4-carboxamider